| 中文名称: | 人血管紧张素II |
| 中文别名: | 血管紧张素II;血管紧张素Ⅱ;[Ile5]-血管紧缩素 2;人血管紧张素II;人血管紧张素II相对分子质量标准物质;人血管紧张肽 II<电离质谱校准物>;血管紧张素II,人;血管紧张肽 II;血管紧张素2;血管紧张肽酰胺;增加压素;增血压素,HYPERTENSIN;人血管紧张肽II;醋酸血管紧张素II |
| smiles: | O=C([C@]([H])(C([H])([H])C1=C([H])N=C([H])N1[H])N([H])C([C@]([H])([C@@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])[H])N([H])C([C@]([H])(C([H])([H])C1C([H])=C([H])C(=C([H])C=1[H])O[H])N([H])C([C@]([H])(C([H])(C([H])([H])[H])C([H])([H])[H])N([H])C([C@]([H])(C([H])([H])C([H])([H])C([H])([H])/N=C(\N([H])[H])/N([H])[H])N([H])C([C@]([H])(C([H])([H])C(=O)O[H])N([H])[H])=O)=O)=O)=O)=O)N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(N([H])[C@]([H])(C(=O)O[H])C([H])([H])C1C([H])=C([H])C([H])=C([H])C=1[H])=O |
| 英文名称: | Angiotensin Ⅱ, human |
| 英文别名: | Angiotensin II,5-L-isoleucine-;Angiotensin Acetate II;Angiotensin II;Angiotensin II, Ang II;Angiotensin II, human;Human angiotension II Relative Molecular Weight;[ILE5]-ANGIOTENSIN 2;[Ile5]angiotensin II;Ang II;Angiotensin Ⅱ, huMan;ANGIOTENSIN-2;angiotensinii(mouse);ANTI-ANGIOTENSIN II;Asp1-Arg2-Val3-Tyr4-Ile5-His6-Pro7-Phe8;Asp-Arg-Val-Tyr-Ile-His-Pro-Phe;DRVYIHPF;H2N-DRVYIHPF-COOH;H-DRVYIHPF-OH;HUMAN;human angiotensin II;Hypertensin;Hypertensin II;ile(5)-angiotensini;TY-10721;Alanine,N-[1-[N-[N-[N-[N-(N2-L-a-aspartyl-L-arginyl)-L-valyl]-L-tyrosyl]-L-isoleucyl]-L-histidyl]-L-prolyl]-3-phenyl-,L- (6CI,7CI);10: PN: WO0212471 SEQID: 17 unclaimed sequence;12: PN: WO0239997 SEQID: 17unclaimed sequence;17: PN:US6610497 SEQID: 17 unclaimed sequence;17: PN: US6884771 SEQID: 17 unclaimedsequence;17: PN: US6989363 SEQID: 17 unclaimed sequence;1:PN: CN1706502 PAGE: 2 claimed sequence;1: PN: US6022696 SEQID: 2 unclaimedsequence;1: PN: WO0002905 SEQID: 1 claimed protein;Angiotensin II human;Angiotensin II (mouse);Angiotensin II (human);Giapreza;5-Isoleucine-angiotensin II;5-L-Isoleucineangiotensin II;Ile(5)-angiotensin II;1-8-Angiotensin I;isoleucine(5)-angiotensin II;CZGUSIXMZVURDU-JZXHSEFVSA-N;M089EFU921;Isoleucine5-angiotensin II;Angiotensin II, ile(5)-;Angiotensin ii [INN:JAN];Angiotensin II (USAN);Angiotensin Ⅱ,human;CHEBI:131170;C75211;DRVY-I*-HPF [I*= I(13C6,15N)];DTXSID4036778;Angiotensin II (human type);(3S)-3-amino-3-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S,2S)-1-{[(2S)-1-[(2S)-2-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}pyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]carbamoyl}-2-methylbutyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-methylpropyl]carbamoyl}-4-[(diaminomethylidene)amino]butyl]carbamoyl}propanoic acid;32044-01-2, 4474-91-3 (salt);BDBM50236697;Angiotensin II (9CI);NS00074073;SCHEMBL9013957;1-L-Aspasaginyl-5-L-valyl angiotensin octapeptide;BDBM50228195;C01CX09;CHEBI:48432;Angiotensin II (human type) (JAN);Angiotensin II (acetate);Ang II (acetate);DRVYIHPF (acetate);D02014;HB3488;CHEBI:2719;DB11842;L-phenylalanine, L-alpha-aspartyl-L-arginyl-L-valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-prolyl-;Angiotensin-(1-8) Octapeptide;Angiotensin 2;ProteoMass(TM) Angiotensin II MALDI-MS Standard, vial of 10 nmol;UNII-M089EFU921;C50H71N13O12;AKOS016010178;Angiotensina II (INN-Spanish);DTXSID30196288;C02135;ANGIOTENSIN II;Angiotensin II heavy;ty-10721;HY-13948;Human angiotensin II;Delivert;Angiotensinum II;(3S)-3-AMINO-3-{[(1S)-4-CARBAMIMIDAMIDO-1-{[(1S)-1-{[(1S)-1-{[(1S,2S)-1-{[(2S)-1-[(2S)-2-{[(1S)-1-CARBOXY-2-PHENYLETHYL]CARBAMOYL}PYRROLIDIN-1-YL]-3-(1H-IMIDAZOL-4-YL)-1-OXOPROPAN-2-YL]CARBAMOYL}-2-METHYLBUTYL]CARBAMOYL}-2-(4-HYDROXYPHENYL)ETHYL]CARBAMOYL}-2-METHYLPROPYL]CARBAMOYL}BUTYL]CARBAMOYL}PROPANOIC ACID;SCHEMBL1189;ANG-(1-8)Octapeptide, Hypertensin, 4474-91-3, Giapreza;Alanine, N-(1-(N-(N-(N-(N-(N2-L-alpha-aspartyl-L-a... |
| CAS号: | 4474-91-3 |
| 分子式: | C50H71N13O12 |
| 分子量: | 1046.18 |
| 密度: | |
| 熔点: | |
| 沸点: | |
| 闪点: | |
| 水溶性: | |
| 蒸气压: |
人血管紧张素II
英文名:
Angiotensin Ⅱ, human
别名:血管紧张素II;血管紧张素Ⅱ;[Ile5]-血管紧缩素 2;人血管紧张素II;人血管紧张素II相对分子质量标准物质;人血管紧张肽 II<电离质谱校准物>;血管紧张素II,人;血管紧张肽 II;血管紧张素2;血管紧张肽酰胺;增加压素;增血压素,HYPERTENSIN;人血管紧张肽II;醋酸血管紧张素II
商品编号:R003142-10mg
规格:10mg
纯度:90%
CAS号: 4474-91-3
分子式:C50H71N13O12
分子量:1046.18
| 价格 |
¥ 284.00
(请 登录 会员查看折扣价)
|
| 货期 | 现货 |
数量
搜索质检报告(COA)
搜索MSDS
相关产品


















